News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Uscom.
RELATED STOCKHEAD STORIES
Health & Biotech
With FDA approval close, Echo IQ’s AI platform is set to disrupt US heart disease market
Health & Biotech
FDA submission looms as Artrya’s AI platform aims to capture the huge cardio diseases market
Experts
CRITERION: Cracking the China nut – it’s the GOAT challenge
Health & Biotech
ASX Health Stocks: Nova Eye faces FDA hurdle in the US, Uscom recognised in China
Health & Biotech
ASX Health Stocks: China likes Uscom device, includes it in national emergency guidelines
Health & Biotech
Here are the ASX heart stocks fighting the number one killer disease in humans
Health & Biotech
China is about to grant patents like never before, and these ASX stocks have already got some
Health & Biotech
ASX Health Stocks: USCOM jumps 12pc on China patent, while Next Science gets TGA nod
Health & Biotech
Dr Boreham’s Crucible: Breaking down the post-COVID market opportunity for Uscom
Health & Biotech
ASX health stocks: Rhinomed rockets 80% after securing first government purchase for COVID-19 Rhinoswabs
News
Last Orders: ASX returns to the green, gaining 0.78 per cent
News
Last Orders: ASX jogs out of the blocks to start the week
Health & Biotech
Heart disease is becoming a bigger problem but these ASX stocks are trying to help with it
Health & Biotech
These four ASX companies are primed to benefit as China accelerates out of COVID-19
Health & Biotech
ASX asthma stocks: Global Health becomes the latest contender
News
What investors should look for in Aussie companies eyeing a China strategy
Health & Biotech
